These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 29475829)

  • 1. The Patient Perspective on the Impact of Tenosynovial Giant Cell Tumors on Daily Living: Crowdsourcing Study on Physical Function and Quality of Life.
    Mastboom MJ; Planje R; van de Sande MA
    Interact J Med Res; 2018 Feb; 7(1):e4. PubMed ID: 29475829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of surgery in tenosynovial giant cell tumours as measured by patient-reported outcomes on quality of life and joint function.
    Verspoor FGM; Mastboom MJL; Hannink G; van der Graaf WTA; van de Sande MAJ; Schreuder HWB
    Bone Joint J; 2019 Mar; 101-B(3):272-280. PubMed ID: 30813787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diffuse-type tenosynovial giant cell tumor (dt-TGCT) patient journey: a prospective multicenter study.
    Bernthal NM; Spierenburg G; Healey JH; Palmerini E; Bauer S; ; Gelderblom H; Staals EL; Lopez-Bastida J; Fronk EM; Ye X; Laeis P; van de Sande MAJ
    Orphanet J Rare Dis; 2021 Apr; 16(1):191. PubMed ID: 33926503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-reported Symptoms of Tenosynovial Giant Cell Tumors.
    Gelhorn HL; Tong S; McQuarrie K; Vernon C; Hanlon J; Maclaine G; Lenderking W; Ye X; Speck RM; Lackman RD; Bukata SV; Healey JH; Keedy VL; Anthony SP; Wagner AJ; Von Hoff DD; Singh AS; Becerra CR; Hsu HH; Lin PS; Tap WD
    Clin Ther; 2016 Apr; 38(4):778-93. PubMed ID: 27041409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher incidence rates than previously known in tenosynovial giant cell tumors.
    Mastboom MJL; Verspoor FGM; Verschoor AJ; Uittenbogaard D; Nemeth B; Mastboom WJB; Bovée JVMG; Dijkstra PDS; Schreuder HWB; Gelderblom H; Van de Sande MAJ;
    Acta Orthop; 2017 Dec; 88(6):688-694. PubMed ID: 28787222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct extra-articular invasion patterns of diffuse pigmented villonodular synovitis/tenosynovial giant cell tumor in the knee joints.
    Kim DE; Kim JM; Lee BS; Kim NK; Lee SH; Bin SI
    Knee Surg Sports Traumatol Arthrosc; 2018 Nov; 26(11):3508-3514. PubMed ID: 29637236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The measurement of physical functioning among patients with Tenosynovial Giant Cell Tumor (TGCT) using the Patient-Reported Outcomes Measurement Information System (PROMIS).
    Gelhorn HL; Ye X; Speck RM; Tong S; Healey JH; Bukata SV; Lackman RD; Murray L; Maclaine G; Lenderking WR; Hsu HH; Lin PS; Tap WD
    J Patient Rep Outcomes; 2019 Feb; 3(1):6. PubMed ID: 30714073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tenosynovial Giant Cell Tumors in Children: A Similar Entity Compared With Adults.
    Mastboom MJL; Verspoor FGM; Uittenbogaard D; Schaap GR; Jutte PC; Schreuder HWB; van de Sande MAJ
    Clin Orthop Relat Res; 2018 Sep; 476(9):1803-1812. PubMed ID: 29494352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pigmented villonodular synovitis: a crowdsourcing study of two hundred and seventy two patients.
    van der Heijden L; Piner SR; van de Sande MA
    Int Orthop; 2016 Dec; 40(12):2459-2468. PubMed ID: 27169531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tenosynovial Giant Cell Tumor Observational Platform Project (TOPP) Registry: A 2-Year Analysis of Patient-Reported Outcomes and Treatment Strategies.
    Palmerini E; Healey JH; Bernthal NM; Bauer S; Schreuder H; Leithner A; Martin-Broto J; Gouin F; Lopez-Bastida J; Gelderblom H; Staals EL; Mercier F; Laeis P; Ye X; van de Sande M
    Oncologist; 2023 Jun; 28(6):e425-e435. PubMed ID: 36869793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arthroscopic Excision of a Localized Tenosynovial Giant Cell Tumor of the Knee: A Case Report.
    Zmerly H; Draghetti M; Moscato M; Akkawi I
    Curr Rheumatol Rev; 2024; 20(4):459-464. PubMed ID: 38231053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Burden of Illness Associated with Tenosynovial Giant Cell Tumors.
    Burton TM; Ye X; Parker ED; Bancroft T; Healey J
    Clin Ther; 2018 Apr; 40(4):593-602.e1. PubMed ID: 29580718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI of diffuse-type tenosynovial giant cell tumour in the knee: a guide for diagnosis and treatment response assessment.
    Spierenburg G; Suevos Ballesteros C; Stoel BC; Navas Cañete A; Gelderblom H; van de Sande MAJ; van Langevelde K
    Insights Imaging; 2023 Feb; 14(1):22. PubMed ID: 36725759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of Tenosynovial Giant Cell Tumor of the Foot and Ankle.
    Barnett JR; Rudran B; Khan A; O'Reilly-Harbidge S; Patel S; Malhotra K; Cullen N; Welck M; Aston W
    Foot Ankle Int; 2023 Oct; 44(10):1013-1020. PubMed ID: 37644900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffuse and localized tenosynovial giant cell tumor and pigmented villonodular synovitis: a clinicopathologic and flow cytometric DNA analysis.
    Abdul-Karim FW; el-Naggar AK; Joyce MJ; Makley JT; Carter JR
    Hum Pathol; 1992 Jul; 23(7):729-35. PubMed ID: 1319390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Giant cell tumor of tendon sheath, tenosynovial giant cell tumor, and pigmented villonodular synovitis: defining the presentation, surgical therapy and recurrence.
    Martin RC; Osborne DL; Edwards MJ; Wrightson W; McMasters KM
    Oncol Rep; 2000; 7(2):413-9. PubMed ID: 10671695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of EQ-5D-5L, VAS, and SF-6D in Thai Patients on Peritoneal Dialysis.
    Thaweethamcharoen T; Noparatayaporn P; Sritippayawan S; Aiyasanon N
    Value Health Reg Issues; 2019 May; 18():59-64. PubMed ID: 30502661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does CSF1 overexpression or rearrangement influence biological behaviour in tenosynovial giant cell tumours of the knee?
    Mastboom MJL; Hoek DM; Bovée JVMG; van de Sande MAJ; Szuhai K
    Histopathology; 2019 Jan; 74(2):332-340. PubMed ID: 30152874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychometric properties of a custom Patient-Reported Outcomes Measurement Information System (PROMIS) physical function short form and worst stiffness numeric rating scale in tenosynovial giant cell tumors.
    Speck RM; Ye X; Bernthal NM; Gelhorn HL
    J Patient Rep Outcomes; 2020 Jul; 4(1):61. PubMed ID: 32676941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic burden and health-related quality of life in tenosynovial giant-cell tumour patients in Europe: an observational disease registry.
    Lopez-Bastida J; Aranda-Reneo I; Rodríguez-Sánchez B; Peña-Longobardo LM; Ye X; Laeis P; Fronk EM; Palmerini E; Leithner A; Van de Sande MAJ
    Orphanet J Rare Dis; 2021 Jul; 16(1):294. PubMed ID: 34215312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.